PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus |
| Phenotype | C0004153|atherosclerosis |
| Sentences | 35 |
| PubMedID- 20682673 | Nuclear magnetic resonance lipoprotein subclasses and the apoe genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 19687018 | Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study. |
| PubMedID- 26251402 | Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 20854650 | Since that time, numerous studies have described the existence of premature subclinical and accelerated atherosclerosis in patients with lupus (reviewed in [3]). |
| PubMedID- 22392450 | This unexpected result clearly demonstrates that, contrary to the common belief, lupus may not lead to accelerated atherosclerosis by driving increased ic deposition within vascular lesions, and other immunologic mechanisms may be more critical. |
| PubMedID- 23084817 | Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials. |
| PubMedID- 23060481 | We hypothesized that increased inflammation is associated with increased ffas, resulting in insulin resistance and atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 25638414 | Striking phenomena of atherosclerosis associated with systemic lupus erythematosus (sle) is its high incidence in young patients. |
| PubMedID- 25159099 | We sought to investigate the relationship between bmd and vf and carotid atherosclerosis in women with systemic lupus erythematosus (sle). |
| PubMedID- 26455562 | Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. |
| PubMedID- 24711757 | Hcq might have improved vascular function in our study population, since it has been shown to exert a mild protective effect against atherosclerosis in patients with systemic lupus erythematosus (45). |
| PubMedID- 24478772 | However, high levels of stweak were associated with atherosclerosis in patients with systemic lupus erythematosus (sle), but not in control subjects (87). |
| PubMedID- 22709931 | The detection of autoantibodies to atp-binding cassette transporter a1 and its role in the pathogenesis of atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 24790989 | atherosclerosis is accelerated in patients with systemic lupus erythematosus (sle) and it leads to excessive cardiovascular complications in these patients. |
| PubMedID- 25247758 | Metabolic syndrome is correlated with carotid atherosclerosis in patients with lupus nephritis. |
| PubMedID- 20132070 | Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 21670088 | High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. |
| PubMedID- 21371346 | Additionally, rosiglitazone, another ppar-γ agonist, decreased aortic atherosclerosis in lupus- and atherosclerosis-prone gld.apoee-/- mice [54]. |
| PubMedID- 24261762 | Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 22957213 | Thrombotic events seem to occur more readily in lupus patients with coexistent atherosclerosis [22]. |
| PubMedID- 21110795 | Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus: comments on the article by mok et al. |
| PubMedID- 26183767 | Cd4+cxcr3+ t cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus. |
| PubMedID- 24699314 | Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 20813797 | To assess aortic stiffness by transesophageal echocardiography (tee) and to determine its clinical predictors and relation to age, blood pressure, renal function, and atherosclerosis, 50 patients with systemic lupus erythematosus (sle), 94% women, with a mean age of 38 +/- 12 years, and 22 age and gender-matched healthy controls underwent clinical and laboratory evaluations and multiplane tee to assess stiffness, intima-media thickness (imt), and plaques of the proximal, mid, and distal descending thoracic aorta. |
| PubMedID- 23620348 | Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 20482780 | We previously established the apoe-/- and faslpr/lpr (fas-/-) double knockout b6 mouse as a model of accelerated atherosclerosis in lupus [16]. |
| PubMedID- 23082493 | Mannose binding lectin gene polymorphism and preclinical carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 23526148 | Th17/treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 23690663 | The same group also reported independent relationships between serum leptin and proinflammatory lipid concentrations as well as atherosclerosis in patients with lupus [33]. |
| PubMedID- 26424129 | Low bone mass and carotid atherosclerosis in lupus erythematosus patients from granada, a city in the south of spain. |
| PubMedID- 22910888 | In addition, very recently, mcmahon and colleagues have demonstrated that leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus and that there is no significant association between adiponectin and atherosclerotic plaques in sle [132]. |
| PubMedID- 22194660 | In addition, very recently, mcmahon and colleagues have demonstrated that leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus and that there is no significant association between adiponectin and atherosclerotic plaques in sle [24]. |
| PubMedID- 24376005 | Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus. |
| PubMedID- 21280004 | Objective: an increased risk of premature atherosclerosis has been associated with systemic lupus erythematosus (sle), and type i interferon (ifn) has been shown to play a pathogenic role in human sle. |
| PubMedID- 23724626 | Background: increased atherosclerosis prevalence in patients with systemic lupus erythematosus (sle) is an epidemiological certainty. |
Page: 1